14 April 2023 in Advanced Ophthalmology
Relevance. Diabetic retinopathy (DR) is a common complication of diabetes mellitus (DM) and the leading causeof blindness worldwide. It is recognized that the foveal avascular zone (FAZ) can increase and become irregular in DR, which,according to some authors, can serve as biomarkers in diagnosing and monitoring the progression of diabetic retinopathy orassessing response to treatment. The purpose of the study was to determine the characteristics of microcirculation in patientswith type 2 diabetes without clinical signs of retinopathy in the fundus and at different stages of DR using the OCT-A method.Material and methods. A clinical study was conducted among 252 people (n=504), of which 168 patients with type 2 diabetesand 84 practically healthy individuals, the average age of which was 57.6 ± 7.8 years, of which 52.6% were men, 47.4% womenResults. As a result of the studies, an increase in the area of the FAZ with the progression of the severity of the disease, aswell as a decrease in the density of parafoveal superficial and deep vessels at different stages of DR, was revealed. In the deepplexus, the decrease in vascular density occurred earlier, manifesting in patients with type 2 diabetes without DR, comparedwith the superficial plexus, where it began with moderate to severe NPDR and was more pronounced in PDR. Conclusion. Thus,a decrease in the density of the capillary network of the deep vascular plexus, which are detected even at the preclinical stagesof the development of DR and increase as the disease progresses. can serve as a marker of disease severity in the early stagesof diabetic retinopathy.
14 April 2023 in Advanced Ophthalmology
Relevance. Early detection of lesions and maintenance of the normal functioning of the retinal tissue at an earlystage of non-proliferative diabetic retinopathy (NPDR) is considered an extremely important step in its secondary prevention,which makes it advisable to include angioprotective drugs in the complex of conservative therapy. One of the drugs of interestis «Dobesilate calcium» drug that improves retinal microcirculation, is able to prevent and correct biochemical changes in nervetissues, and has an endothelioprotective effect. The purpose of the study. The aim of the study was to evaluate the effectivenessof the use of the drug «Dobesilate calcium» in patients with an early stage of NPDR. Material and methods. 60 patients (120eyes) were examined, the average age of which was 59.4±6.2 years, of which 52.6% were men, 47.4% were women. Results.Analysis of the results showed that in the group of patients who received «Dobesilate calcium» there was an improvement invisual acuity by an average of 0.20±0.02 (p<0.05), a decrease in the thickness of the retina (CTS) by an average of 1.60 micron(p0.05). Conclusion. This studyshowed that the treatment with the drug «Dobesilate calcium» helps to improve eye blood flow in retrobulbar vessels, whichmakes it possible to recommend the specified method of treatment for the secondary prevention of the development of diabeticretinopathy and restorative treatment of patients from the early stages of the NDPR.
1 December 2020 in Ophthalmology Reports
МШМиррахимова Саидахон Шухратовна
Миррахимова Саидахон Шухратовна
Relevance. In the treatment of inflammatory diseases of the ocular surface, in order to achieve high efficiency in the shortest possible time, it is necessary for the therapy to be comprehensive. Today, in addition to traditional treatment methods, new technologies based on the use of low-energy lasers, which have high biological activity, are spreading. Aim. To improve the treatment results of the inflammatory diseases of the ocular surface by implementing photodynamic therapy (PDT) in experiment and clinic, using domestic equipment and elaborating optimal energetic parameters of laser irradiation. Methods. Objects of research: 130 nonlinear sexually mature rats weighing 150 grams contained in standard vivarium conditions and 110 eyes of patients with inflammatory eye diseases. Carrying out the investigation, experiments on animals, clinical and functional examination results of patients, and statistical analysis were taken into consideration. Results. A methodology for complex treatment of inflammatory diseases of the ocular surface was developed (with inclusion of PDT by the laser therapy device Vostok), based on experimental data and confirmed by clinical and functional ocular indices. PDT helps to increase the effectiveness of treatment, which is manifested by accelerated tissue regeneration, restoration of corneal transparency, increase of visual function in 86.7%, and reduction of treatment terms to 6 days. Conclusions. Anti-inflammatory and regenerative effectiveness of the proposed complex treatment of inflammatory diseases of the ocular surface with the PDT use was established: improvement in the clinical picture of conjunctivitis and keratitis was revealed, manifested by increase in corneal epithelization.
22 February 2023 in Advanced Ophthalmology
Relevance. Despite modern advances in medicine, type 2 diabetes mellitus (DM 2) still remains an important medical and social problem due to the frequency and severity of complications. The purpose of our study. The aim of the study was to evaluate the relationship between the levels of vascular growth factor (VEGF) and brain-derived neurotrophic factor (BDNF) in blood serum and the area of the foveal avascular zone (FAZ) on OCT-A in patients with type 2 diabetes mellitus (DM2), with various stages DR. Materials and methods. A clinical study was conducted among 252 people (n=504), of which 168 patients with type 2 diabetes and 84 practically healthy individuals, the average age of which was 57.6 ± 7.8 years, of which 52.6% were men, 47.4% women. Results. As a result of the studies, an increase in the level of VEGF in the blood serum before the onset of DR clinically was revealed 137.2 ± 84.4 pg/ml (group II of comparison). It was found that the level of VEGF correlated with the levels of BDNF in the serum of patients and with the stage of retinopathy (p<0.05). Based on the studies performed, it was suggested that a mild deficiency with plasma BDNF less than 0.62 ng/ml indicates DR in general, and a BDNF level < 0.22 ng/ml indicates the development of PDR and/or diabetic macular ischemia (DME). Thus, a low level of BDNF and a high level of VEGF in serum can be potential risk factors for DR in T2 DM and serve as its diagnostic indicators.
10 January 2013 in Oftalmologicheskii Zhurnal
TATashkent Medical Academy
14 April 2023 in Advanced Ophthalmology
2023-йил 28-март куни Ўзбекистон Республикасида ҳизмат кўрсатган тиббиёт ходими, Республика офтальмологлар ассоциацияси раиси, кўп тармоқли DMC - Доктор Мақсудова инновацион клиникаси директори, Мақсудова Зулфия Рузметовна таваллудининг 70 йиллиги нишонланади.